PREVALENCE AND RISK FACTORS OF GESTATIONAL DIABETES MELLITUS
Introduction. Gestational diabetes mellitus (GDM) is currently the most common form of metabolic disorder in pregnant women, the consequences of which are significant for doctors of various specialties. According to the Atlas of the International Diabetes Federation (IDF) for 2021, more than 21 million children were born to mothers with various forms of carbohydrate metabolism disorders, the bulk of which, 80.3%, were GDM. [49]. The rapid increase in the number of patients with GDM, on the one hand, is associated with the increasing influence of risk factors such as maternal age, excess weight, sedentary lifestyle of women, and on the other hand, with the introduction of new criteria for its definition into practice
In some countries, the prevalence of GDM reaches 17.8–41.9% (using the criteria of the International Association of Diabetes and Pregnancy Study Groups (IADPSG)). [42]. Thus, the prevalence of GDM in pregnant women at the present stage is becoming an important medical and social problem for both the mother and the fetus.
Aim: study of the prevalence and risk factors for the development of gestational diabetes mellitus according to literature data.Search strategy.
Search strategy: The search for scientific publications was carried out in the databases: PubMed, Medline, eLibrary, using the scientific search engine Google Scholar. Search depth - 10 years. A total of 263 sources were found, from which 80 publications were selected for subsequent analysis. Inclusion criteria: publications in Russian and English; publications included in the PubMed, Medline, e-Library databases. Exclusion criteria: publications without a clear formulation of results and conclusions; articles, abstracts with paid access.
Results and conclusions. Results and conclusions. Gestational diabetes mellitus (GDM) is the most common disease among pregnant women, affecting up to 15-25% worldwide. GDM occurs due to impaired glucose regulation during pregnancy, which leads to severe consequences not only for the mother's body, but also for the fetus. The problem is interdisciplinary, i.e. it requires close attention from both obstetricians and gynecologists and endocrinologists.
Keywords: Gestational diabetes mellitus, preelampsia, hypokinetics, hypoxia, glycemia.
Kamalzhan T. Nadyrov1, https://orcid.org/0000-0002-0673-2208
Umytzhan S. Samarova2, https://orcid.org/0000-0002-8037-2677
Аigerim Е. Malgazhdarova2, https://orcid.org/0000-0002-8037-2677
Gulnoza U. Aldabekova1, https://orcid.org/0009-0009-1561-1094
Svetlana B. Abdrashidova1, https://orcid.org/0009-0005-1464-131Х
Ахметова Е.С., Ларева Н.В., Мудров В.А. и др. Особенности течения беременности при гестационном сахарном диабете и прогнозирование диабетической фетопатии. Журнал акушерства и женских болезней. 2017. Т.66. №4. С.14–24. doi: 10.17816/JOWD66414-24.
2. Бардымова Т.П., Березина М.В., Михалева О.Г., Мистяков М.В. Ожирение и гестационный сахарный диабет. Сибирский медицинский журнал (Иркутск), 2015, № 4. С.10-15.
3. Белоцерковцева Л.Д, Коваленко Л.В., Каспарова А.Э. и др. Эволюция диагностических критериев гестационного сахарного диабета. Вестник СурГУ. Медицина. 2014. №3 (21), С.9-15.
4. Бондарь И.А., Малышева А.С. Осложнения и исходы беременности при гестационном сахарном диабете. Бюллетень сибирской медицины, 2014, Т.13, №2, С. 5–9.
5. Бехбуди-Гандевани С., Амири М., Яранди Р.Б., Техрани О.Р. Влияние диагностических критериев гестационного диабета на его распространенность: систематический обзор и мета-анализ. Синдром Диабетол Метаб. 2019.11:11. doi: 10.1186/s13098-019-0406-1.
6. Ботагарова А.К. Проблема гестационного диабета в Республике Казахстан. MEDICINE. 2015. №7, С.74-76.
7. Бурумкулова Ф.Ф., Петрухин В.А. Гестационный сахарный диабет: вчера, сегодня, завтра. Терапевтический архив. 2014. Т. 86, № 10. С. 109-115.
8. Бутрова С.А. От эпидемии ожирения к эпидемии сахарного диабета. Новости медицины и фармации. 2013. №1. С. 24-28.
9. Всемирная организация здравоохранения. Диагностические критерии и классификация гипергликемии, впервые выявленной во время беременности. Женева, Швейцария: ВОЗ. 2013. https://apps.who.int/iris/handle/10665/85975 [Дата обращения 21.02.2021].
10. Гиниятуллина Е.Н., Есаян Р.М., Колегаева О.И., Торшхоева Х.М., Ткачева О.Н. Гестационный диабет: Распространенность и факторы риска ГСД. Проблемы эндокринологии. 2012. 4, выпуск 2. С.13-16
11. Григорян О.Р., Михеев Р.К., Куринова А.Н. и др. Сравнительный анализ влияния факторов риска на течение и исходы беременности с гестационным сахарным диабетом. Проблемы Эндокринологии. 2021, 67(3):78-86. doi: 10.14341/проблема 12756
12. Дзугкоев С.Г., Тедтоева А.И., Дзугкоева Ф.С., Можаева И.В., Маргиева О.И. Оценка биохимических показателей у беременных с метаболическими нарушениями: результаты сравнительного исследования. Акушерство, Гинекология и Репродукция. 2017. 11(2):12-17. https://doi.org/10.17749/2313-7347.2017.11.2.012-017.
13. Давыдова И.И. Гестационный сахарный диабет: факторы риска, диагностика, лечение (обзор литературы). Молодой ученый. 2019. №28 (266). С. 173-176.
14. Дедов И.И., Мельниченко Г.А., Фадеев В.В. Эндокринология. - М. : Литера, 2015. 416 с.
15. Додхоева М.Ф., Пирматова Д.А. Гестационный сахарный диабет: современный взгляд на актуальную проблему. Вестник авиценны. 2018. Т.20, №4 doi: 10.25005/2074-0581-2018-20-4-455-461
16. Забаровская З.В. Прегестанционные и гестационные факторы риска развития гестационного сахарного диабета. Военная медицина 2009 №4(15). С.52-56.
17. Краснопольский В.И., Петрухин В.А., Бурумкулова Ф.Ф. Гестационный сахарный диабет – новый взгляд на старую проблему. Акушерство и гинекология. 2016. №2. С. 3-6.
18. Ларькин Д.М. Оптимизация акушерских и пери-натальных исходов у пациенток с гестационным сахарным диабетом. Канд.диссер. Екатеринбург. 2016. 114 с.
19. Международная федерация диабета. Отчет о диабете в Европе за 2010 - 2045гг. 2020. https://diabetesatlas.org/data/en/region/3/eur.html.
20. Никонова Л.В., Тишковский С.В., Бутрим О.С., Гестационный сахарный диабет: генетические маркеры инсулинорезистентности, диагностические критерии и тактика ведения. Журнал Гродненского государственного медицинского университета, 2020. Т.18, № 6, doi:10.25298/2221-8785-2020-18-6-732-738.
21. Нуртазина А.У., Кошпесова Г.К., и др. Ожирение, сахарный диабет и артериальная гипертензия - глобальные проблемы современного общества. Обзор литературы. Наука и Здравоохранение, 2021. 5 (Т.23). С.149-160
22. Пакин В.С. Молекулярно-генетические аспекты гестационного сахарного диабета. http://dx.doi.org/10.14341/probl2017633204-207
23. Петросян Г.Т., Прищеп М.В., Смирнова Т.И. Факторы риска гестационного сахарного диабета // Смоленский медицинский альманах. 2021. №3, С.69-72.
24. Петунина Н.А., Кузина И.А. Роль гормонов жировой ткани в развитии осложнений беременности у женщин с ожирением. Ожирение и метаболизм. 2013. №1, С.3-8.
25. Разина А.О., Ачкасов Е.Е., Руненко С.Д. Ожирение: современный взгляд на проблему. Ожирение и метаболизм. 2016. Т.13. №1. С. 3-8.
26. Сметанина С.А., Суплотова Л.А., Бельчикова Л.Н., Новаковская Н.А. Распространенность нарушений углеводного обмена у женщин Крайнего Севера в период беременности. Материалы Всероссийский диабетологический конгресс. М., 2010. 462 с.
27. Соболева Н.П. Биоимпедансный скрининг населения России в центрах здоровья: распространенность избыточной массы тела и ожирения. Российский медицинский журнал. 2014. №4 C. 4-13.
28. Тененбаум-Гавиш К., Ход М. Влияние ожирения матери на здоровье плода. Диагностика плода. 2013. 34(1):1-7.
29. Терехин С.П., Ахметова С.В., Молотов-Лучанский В.Б., Проблема неинфекционных алиментарно-зависимых заболеваний в современном мире // Медицина и экология. 2018. №2. С.40-47.
30. Шукурхужаева Д.Н., Мухамедханова Ш.Т., Юлдашева Д.С. [и др.]. Роль ожирения и избытка массы тела как фактор развития гестационного сахарного диабета. Молодой ученый. 2022. № 49 (444). С. 525-528. https://moluch.ru/archive/444/97231/
31. Abbas Alam Choudhury, V Devi Rajeswari Gestational diabetes mellitus - A metabolic and reproductive disorder. PMID:34560536 DOI:10.1016/j.biopha.2021.112183 [PubMed] [CrossRef] [Google Scholar]
32. Abdel Hameed Mirghani Dirar, John Doupis. Gestational diabetes from A to Z. World J Diabetes. 2017. № 8(12). С. 489–511. Published online 2017 Dec 15. doi: 10.4239/wjd.v8.i12.489
33. American Diabetes Association Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes - 2018. Diabetes Care. 2018. 41:S13–S27. doi:10.2337/dc18-S002. [PubMed] [CrossRef] [Google Scholar]
34. American Diabetes Association 2. Classification and diagnosis of diabetes: Standards of medical care in diabetes—2020. Diabetes Care. 2020. 43:S14–S31. doi:10.2337/dc20-S002. [PubMed] [CrossRef] [Google Scholar]
35. American Diabetes Association Professional Practice Committee. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022 Jan 1. 45(Suppl 1):S17-S38. doi: 10.2337/dc22-S002. PMID: 34964875.
36. Brustman L.E., Langer O., Bimson B., et al. Weight gain in gestational diabetes: the effect of treatment modality. J Matern Fetal Neonatal Med. 2015. Vol. 22. P.1-5. [PubMed] [Google Scholar].
37. Cameron D.M., Evans J.M. Prevalence of gestational diabetes mellitus in Europe: a meta-analysis. Diabetes Research and Clinical Practice, 2017.р.173-181
38. Carroll X., Liang X., Zhang W., Zhang W., Liu G., Turner N., Leeper-Woodford S. Socioeconomic, environmental and lifestyle factors associated with gestational diabetes mellitus: A matched case-control study in Beijing, China. Sci. Rep. 2018. 8:8103. doi:10.1038/s41598-018-26412-6. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
39. Gao C., Sun X., Lu L., Liu F., Yuan J. Prevalence of gestational diabetes mellitus in mainland China: A systematic review and meta-analysis. J. Diabetes Investig. 2018;10:154–162. doi:10.1111/jdi.12854. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
40. Chiswick C.A., Reynolds R.M., Denison F.C., et al. Efficacy of metformin in pregnant obese women: a randomised controlled trial. BMJ Open. 2015. Vol. 5. №1. P.54-68.
41. Choi J., Fukuoka Y., Lee J.H. The effects of physical activity and physical activity plus diet interventions on bodyweight in overweight or obese women who are pregnant or in postpartum: A systematic review and meta-analysis of randomized controlled trials. Preventive Medicine. 2013. Vol. 56. №6. Р.351-364.
42. Gopalakrishnan V., Singh R., Pradeep Y., Kapoor D., Rani A.K., Pradhan S. et al. Evaluation of the prevalence of gestational diabetes mellitus in North Indians using the International Association of Diabetes and Pregnancy Study groups (IADPSG) criteria. J Postgrad Med. 2015 Jul-Sep. 61(3):155-8. doi: 10.4103/0022-3859.159306
43. Delanerolle G. et al. A systematic review and meta-analysis of gestational diabetes mellitus and mental health among BAME populations. EClinicalMedicine. 2021. Т. 38. С. 101016.[PubMed] [CrossRef] [Google Scholar]
44. Damm P., Houshmand‐Oeregaard A., Kelstrup L., Lauenborg J., Mathiesen E.R., Clausen T.D. Gestational diabetes mellitus and long‐term consequences for mother and offspring: a view from Denmark. Diabetologia. 2016. 59(7):1396‐1399. [PubMed] [Google Scholar]
45. Federation I.D. IDF Diabetes Atlas. 9th edition Brussels, Belgium: International Diabetes Federation. 2019. – 47 с.
46. Hu J. et al. Association of maternal lipid profile and gestational diabetes mellitus: A systematic review and meta-analysis of 292 studies and 97,880 women. E Clinical Medicine. 2021. Т. 34. С. 100830. [PubMed] [CrossRef] [Google Scholar]
47. International Diabetes Federation (IDF). Diabetes Atlas, 7th edn. Brussels: International Diabetes Federation; 2015. [Google Scholar]
48. International Diabetes Federation. IDF Diabetes Atlas. 8th ed. IDF; Brussels, Belgium: 2017. [Google Scholar]
49. International Diabetes Federation. IDF Diabetes Atlas, 10th edn. Brussels, Belgium: 2021. Available at: https://www.diabetesatlas.org
50. Juan J., Yang H.-X., Su R.-N., Kapur A. Diagnosis of Gestational Diabetes Mellitus in China. Matern. Med. 2019. 1:31–37. doi: 10.1097/fm9.0000000000000008. [CrossRef] [Google Scholar]
51. Juan Juan, Huixia Yang Prevalence, Prevention, and Lifestyle Intervention of Gestational Diabetes Mellitus in China. Published online 2020 Dec 18. doi:10.3390/ijerph17249517. PMC free article] [PubMed] [CrossRef] [Google Scholar]
52. Yu Zhu, QingXiang Zheng, YuQing Pan, XiuMin Jiang, JiaNing Li, RuLin Liu, Ling Huang Association between prepregnancy body mass index or gestational weight gain and adverse pregnancy outcomes among Chinese women with gestational diabetes mellitus: a systematic review and meta-analysis. BMJ Open. 2024 Feb 17;14(2):e075226. doi: 10.1136/bmjopen-2023-075226.
53. Kuo C.H., Chen S.C., Fang C.T., Nien F.J., Wu E.T., Lin S.Y., et al. Screening gestational diabetes mellitus: The role of maternal age. PLoS ONE. 2017. 12:3. Available from http://dx.doi.org/10.1371/journal.pone.0173049.
54. Kai Wei Lee, Siew Mooi Ching, Vasudevan Ramachandran, Anne Yee, Fan Kee Hoo, Yook Chin Chia, et al. Prevalence and risk factors of gestational diabetes mellitus in Asia: a systematic review and meta-analysis 2018 Dec 14. 18(1):494.doi: 10.1186/s12884-018-2131-4 [PubMed] [CrossRef] [Google Scholar]
55. Kleinwechter H., Demandt N. Diabetes in Pregnancy — Type 1/Type 2 Diabetes Mellitus and Gestational Diabetes Mellitus. Dtsch Med Wochenschr. 2016. 141(18):1296-1303. doi: 10.1055/s-0042-110555
56. Liu B. et al. Early Diagnosis of Gestational Diabetes Mellitus (EDoGDM) study: a protocol for a prospective, longitudinal cohort study. BMJ open. 2016. Т. 6. №11. С. e012315.
57. Lowe W.L., Scholtens D.M., Kuang A., Linder B., Lawrence J.M., Lebenthal Y., McCance D.R., Hamilton J., et al. Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study (HAPO FUS): Maternal Gestational Diabetes Mellitus and Childhood Glucose Metabolism. Diabetes Care. 2019. 42:372–380. doi:10.2337/dc18-1646. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
58. Mao L., Ge X., Xu Y. Pregestational body mass index,weight gain during first half of pregnancy and gestational diabetes mellitus: a prospective cohort study. Zhonghua Liu Xing Bing Xue Za Zhi. 2015. Vol. 36. №5. P.416-420.
59.Macaulay S., Dunger D.B., Norris S.A. Gestational diabetes mellitus in Africa: a systematic review. PloS one. 2014. Т.9. №6. С. e97871. [PubMed] [CrossRef] [Google Scholar]
60. Martis R., Crowther C.A., Shepherd E., Alsweiler J., Downie M.R., Brown J. Treatments for women with gestational diabetes mellitus: An overview of Cochrane systematic reviews. Cochrane Database Syst Rev. 2018. 8(8):CD012327. [PMC free article] [PubMed] [Google Scholar]
61.Meinila J., Koivusalo S.B., Valkama A., et al. Nutrient intake of pregnant women at high risk of gestational diabetes. Food Nutr Res. 2015. Vol. 59. Р.266-276
62. Mirghani Dirar A., Doupis J. Gestational diabetes from A to Z. World J Diabetes. 2017. 8(12):489-506. Available from http://dx.doi.org/10.4239/ wjd.v8.i12.489.
63. Mishra S., Rao C.R., Bhadoria A.S., Mohanty S., Kishore S., Chaudhary A.S. Life‐cycle approach for prevention of gestational diabetes mellitus. Clin Epidemiol Global Health. 2019. 7(3):418‐423. [Google Scholar]
64. Mission J.F., Marshall N.E., Caughey A.B. Pregnancy Risks Associated with Obesity. Obstet Gynecol Clin North Am. 2015. Vol. 42. №2. Р.335-353.
65. Morampudi S., Balasubramanian G., Gowda A., Zomorodi B., Patil A.S. The challenges and recommendations for GDM care in India: a review. Frontiers in Endocrinology. 2017. 8(56):1-10. Available from http://dx.doi.org/10.3389/ fendo.2017.00056 [PMC free article] [PubMed] [Google Scholar.
66. Much A., Olayemi O., Goethe Y. Prevalence and determinants of gestational diabetes mellitus in Africa based on updated international diagnostic criteria: a systematic review and meta-analysis. Arch Public Health. 2019. 77:36.
67. Mpondo B.C., Ernest A., Dee H.E. Gestational diabetes mellitus: challenges in diagnosis and management. J Diabetes Metab Disord. 2015. Vol. 12. Р.14-42.
68. National Institute for Health and Care Excellence (NICE) Guideline. 2015. Diabetes and Pregnancy: management of diabetes ant its complications from preconception to the postnatal period; cited 2016 Jul 18. URL: https://www.nice.org.uk/guidance/ng3/resources/
69. Noctor E., Dunne F.P. Type 2 diabetes after gestational diabetes: the influence of changing diagnostic criteria. World J Diabet. 2015. 6(2):234‐244. [PMC free article] [PubMed] [Google Scholar]
70. Obesity in Canada: A joint report from the Public Health Agency of Canada and the Canadian Institute for Health Information. www.publichealth.gc.ca.
71. Paýlo M.S., Abdo N.M., Betankýr-Sılva R., Al-Rıfaı R.H. Gestatsıonnyı saharnyı dıabet v Evrope: sıstematıcheskıı obzor ı meta-analız ıssledovanıı rasprostranennostı [Gestational diabetes mellitus in Europe: a systematic review and meta-analysis of prevalence studies] Front Endocrinol. 2021;12:691033. [in French]
72. Plows J., Stanley J., Baker P. et al. The Pathophysiology of Gestational Diabetes Mellitus. Int J Mol Sci. 2018. 19(11):3342. doi: https://doi.org/10.3390/ijms19113342
73. Rayanagoudar G., Hashi A.A., Zamora J., Khan K.S., Hitman G.A., Thangaratinam S. Quantification of the type 2 diabetes risk in women with gestational diabetes: a systematic review and meta‐analysis of 95,750 women. Diabetologia. 2016. 59(7):1403‐1411. [PMC free article] [PubMed] [Google Scholar]
74. Shepherd E., Gomersall J.C., Tieu J., Han S., Crowther C.A., Middleton P. Combined diet and exercise interventions for preventing gestational diabetes mellitus. Cochrane Database Syst Rev. 2017. 2017(11). [PMC free article] [PubMed] [Google Scholar]
75. Torloni M.R., Betrán A.P., Horta B.L., et al. Prepregnancy BMI and the risk of gestational diabetes: a systematic review of the literature with meta-analysis. Obes. Rev. 2009. Vol. 10. №2. Р.194-203.
76. Vounzoulaki E., Khunti K., Abner S.C., Tan B.K., Davies M.J., Gillies C.L. Progression to type 2 diabetes in women with a known history of gestational diabetes: Systematic review and meta-analysis. BMJ. 2020. 369:m1361. doi:10.1136/bmj.m1361. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
77. Wang Y., Luo B. Risk factors analysis of gestational diabetes mellitus based on International Association of Diabetes Pregnancy Study Groups criteria. Nan Fang Yi Ke Da Xue Xue Bao. 2019. 39:572–578. doi:10.12122/j.issn.1673-4254.2019.05.12. (In Chinese). [PMC free article] [PubMed] [CrossRef] [Google Scholar]
78. Wang Y.-Y., Liu Y., Li C., Lin J., Liu X., Sheng J.-Z., Huang H.-F. Frequency and risk factors for recurrent gestational diabetes mellitus in primiparous women: A case control study. BMC Endocr. Disord. 2019. 19:1–7. doi:10.1186/s12902-019-0349-4. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
79. Wang N., Lu W., Xu Y., Mao S. et al. Recurrence of diet-treated gestational diabetes in primiparous women in northern Zhejiang, China: Epidemiology, risk factors and implications. J. Obstet. Gynaecol. Res. 2018. 44:1391–1396. doi:10.1111/jog.13688. [PubMed] [CrossRef] [Google Scholar]
80. Wu L., Han L., Zhan Y., et al. Prevalence of gestational diabetes mellitus and associated risk factors in pregnant Chinese women: A cross-sectional study in Huangdao, Qingdao, China. Asia Pac. J. Clin. Nutr. 2018. 27:383–388. doi:10.6133/apjcn.032017.03. [PubMed] [CrossRef] [Google Scholar]
81. Zheng S., Cheng J., Zheng J. Maternal resveratrol consumption and its programming effects on metabolic health in offspring mechanisms and potential implications. Biosci Rep. 2018. 38(2):BSR20171741. [PMC free article] [PubMed] [Google Scholar]
82. Zhu W.-W., Yang H.-X., Wang C., et al. High Prevalence of Gestational Diabetes Mellitus in Beijing. Chin. Med J. 2017. 130:1019–1025. doi:10.4103/0366-6999.204930. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
Number of Views: 157
Bibliography link
Nadyrov K.T., Samarova U.S., Malgazhdarova A.E., Aldabekova G.U., Abdrashidova S.B. Prevalence and risk factors of gestational diabetes mellitus // Nauka i Zdravookhranenie [Science & Healthcare]. 2024. Vol.26 (3), pp. 164-174. doi 10.34689/SH.2024.26.3.019Related publications:
CHARACTERISTICS OF THE INTESTINAL MICROBIOME IN STROKE PATIENTS WITH INSULIN RESISTANCE
REACTIVE ARTHRITIS IN THE CONTEXT OF CONNECTIVE TISSUE DYSPLASIA – THE ROLE OF THE ORGANISM'S MICROBIOME
EMBOLIZATION OF THE UTERINE ARTERIES FOR LATE POSTPARTUM HEMORRHAGE DUE TO METROENDOMETRITIS: A CLINICAL CASE
DESCRIPTION OF A CLINICAL CASE OF GENERALIZED LYMPHADENOPATHY OF UNKNOWN ETIOLOGY
CLINICAL RELEVANCE OF KRAS MUTATION TESTING IN METASTATIC COLORECTAL USING DIFFERENT SEQUENCING PLATFORMS: A CASE REPORT